Rosenfeld LE, Maulion C. Defibrillators in heart transplant patients: Not always a shockingly good choice.
J Cardiovasc Electrophysiol 2022;
33:1823-1825. [PMID:
35671360 DOI:
10.1111/jce.15587]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/01/2022] [Accepted: 06/05/2022] [Indexed: 11/30/2022]
Abstract
We know that cardiac implantable cardioverter-defibrillators (ICD)s save lives. The pivotal studies done around 20 years ago confirmed the value of these devices for both primary and secondary prevention of sudden cardiac death (SCD)1-3 and have led to guideline recommendations for their use in patients with prior episodes of life-threatening sustained ventricular arrhythmias (Class I) or heart failure and a left ventricular ejection fraction (LVEF) of < 35% (Class I) This article is protected by copyright. All rights reserved.
Collapse